Predicting Cardiac Disease Based on Troponin Levels in Children and Adolescents

Abstract Objectives Cardiac troponin (cTn) is frequently used to evaluate pediatric patients with suspected cardiac disease, yet reference thresholds remain poorly established. This study evaluated associations between troponin levels and cardiac pathology identified through diagnostic testing and sought a threshold to identify patients at low risk for cardiac magnetic resonance (CMR)-confirmed myocarditis. Study Design: This single-center retrospective study included patients aged 1–18 years with at least one elevated troponin measurement defined as > 0.029ng/mL at Nationwide Children’s Hospital between January 2014 and December 2024. Medical records were reviewed for cardiac testing, inpatient events, arrhythmias, and outpatient outcomes. Cut point analysis was performed to maximize sensitivity and specificity, with additional analysis targeting a high-sensitivity threshold for CMR-confirmed myocarditis. Results Among 352 patients, troponin demonstrated limited predictive value for abnormalities on echocardiography, electrocardiography, Holter monitoring, and exercise stress testing. Among 149 patients undergoing acute CMR evaluation, a peak troponin threshold of 0.2 ng/mL yielded 95% sensitivity and an 86% negative predictive value for CMR-confirmed myocarditis. Of the patients with a peak troponin below 0.2 ng/mL with an initial normal echocardiogram and electrocardiogram, three patients had recorded inpatient arrhythmia with no sudden cardiac arrests, readmissions, or deaths. Conclusions Troponin elevation demonstrated limited predictive utility across most cardiac diagnostic modalities in children. A peak troponin threshold of 0.2 ng/mL may help guide CMR evaluation and risk stratification. In selected patients, this threshold may inform decisions regarding further evaluation and disposition. Prospective multicenter studies are needed to validate these findings and establish evidence-based clinical recommendations.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11553962/v1
Primary Topic
Viral Infections and Immunology Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Predicting Cardiac Disease Based on Troponin Levels in Children and Adolescents

Daniel Lubarsky, Julie B. Aldrich, Megan E. Gunsaulus, Lydia Wright et al.
Research Square
Viral Infections and Immunology Research
preprint

Predicting Cardiac Disease Based on Troponin Levels in Children and Adolescents

Daniel Lubarsky, Julie B. Aldrich, Megan E. Gunsaulus, Lydia Wright, Isaac S. Kistler, Christopher Jones, Olivia Marie Groves, Phillip Cheng
preprint en

Abstract

Abstract Objectives Cardiac troponin (cTn) is frequently used to evaluate pediatric patients with suspected cardiac disease, yet reference thresholds remain poorly established. This study evaluated associations between troponin levels and cardiac pathology identified through diagnostic testing and sought a threshold to identify patients at low risk for cardiac magnetic resonance (CMR)-confirmed myocarditis. Study Design: This single-center retrospective study included patients aged 1–18 years with at least one elevated troponin measurement defined as > 0.029ng/mL at Nationwide Children’s Hospital between January 2014 and December 2024. Medical records were reviewed for cardiac testing, inpatient events, arrhythmias, and outpatient outcomes. Cut point analysis was performed to maximize sensitivity and specificity, with additional analysis targeting a high-sensitivity threshold for CMR-confirmed myocarditis. Results Among 352 patients, troponin demonstrated limited predictive value for abnormalities on echocardiography, electrocardiography, Holter monitoring, and exercise stress testing. Among 149 patients undergoing acute CMR evaluation, a peak troponin threshold of 0.2 ng/mL yielded 95% sensitivity and an 86% negative predictive value for CMR-confirmed myocarditis. Of the patients with a peak troponin below 0.2 ng/mL with an initial normal echocardiogram and electrocardiogram, three patients had recorded inpatient arrhythmia with no sudden cardiac arrests, readmissions, or deaths. Conclusions Troponin elevation demonstrated limited predictive utility across most cardiac diagnostic modalities in children. A peak troponin threshold of 0.2 ng/mL may help guide CMR evaluation and risk stratification. In selected patients, this threshold may inform decisions regarding further evaluation and disposition. Prospective multicenter studies are needed to validate these findings and establish evidence-based clinical recommendations.

Research Square
Nationwide Children's Hospital (US)
Good health and well-being
Viral Infections and Immunology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon